Biotech
NORWOOD, MA: Resunab Is a First-in-Class Drug That Induces Resolution of Inflammation; Study Will Treat Each Patient for 84 Days and Is Scheduled to Conclude in Q4 2016 ...
MINNEAPOLIS, MN: Phase 1 Clinical Study Expected to Begin by End of Year ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/31/15 -- (OTCQB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing i ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 08/28/15 -- BioNeutra Global Corporation ("BioNeutra" or the "Company") (CSE: BGA) is pleased to announce today its interim financial result ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 08/27/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer and other members of the managem ...
NORWOOD, MA: Proceeds to Fund Resunab(TM) Phase 2 Studies in Cystic Fibrosis, Systemic Sclerosis and Dermatomyositis; Company Has $14.2 Million of Cash Together With $3.8 Million in Expected Milestone Payments to ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/27/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that the company has initiated a Phase 2 clinical trial of tarloxotinib bromide, ...
LAVAL, QUEBEC: - PBI-4050 confirmed to be safe and well tolerated in the first 12 metabolic syndrome patients - Positive safety review by the Data Safety Monitoring Board ("DSMB") triggers enrollment of 24 ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 08/26/15 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializa ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/25/15 -- InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE: IN)(OTCQB: IMLFF), a biopharmaceutical company specializin ...
MOUNTAIN VIEW, CA: MOUNTAIN VIEW, CA -- (Marketwired) -- 08/24/15 -- The second annual successfully concluded Friday at the Hyatt Regency San Francisco Airport Hotel in Burlingame, CA. The conference, which is hosted ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 08/24/15 -- BioNeutra Global Corporation ("BioNeutra" or the "Company") (CSE: BGA) is very pleased to announce the successful completion of ...
SAN FRANCISCO, CA and SAN RAFAEL, CA: Talazoparib Is a Highly-Potent PARP Inhibitor in Phase 3 Development for the Treatment of BRCA-Mutated Breast Cancer; Clinical Activity Observed in Multiple Oncology Opportunities With Potential for M ...
HUDSON, NEW YORK: Taconic Awards Integrated Solution as Sponsor of Rare Disease Challenge ...
SAN ANTONIO, TEXAS: SAN ANTONIO, TEXAS -- (Marketwired) -- 08/21/15 -- Nerium Biotechnology, Inc. (the "Company") reported today that its subsidiary, Nerium Skincare, Inc., has filed a claim in Texas against ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/20/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company that has trea ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/20/15 -- BIOflex Technologies Inc. (TSX VENTURE: BFT) (the "Company" or "BIOflex") is pleased to announce the appointment of Ms. Leena Lak ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/20/15 -- InMed Pharmaceuticals Inc. ("InMed") (CSE: IN)(OTCQB: IMLFF), a biopharmaceutical company specializing in the research and devel ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/19/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...
